nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR8—lymphoid tissue—colon cancer	0.036	0.173	CbGeAlD
Imiquimod—TLR8—bone marrow—colon cancer	0.0328	0.157	CbGeAlD
Imiquimod—TLR8—liver—colon cancer	0.0265	0.127	CbGeAlD
Imiquimod—TLR7—lymphoid tissue—colon cancer	0.0227	0.109	CbGeAlD
Imiquimod—TLR8—lymph node—colon cancer	0.0203	0.0975	CbGeAlD
Imiquimod—TLR7—vagina—colon cancer	0.0198	0.0951	CbGeAlD
Imiquimod—TLR7—liver—colon cancer	0.0167	0.0802	CbGeAlD
Imiquimod—TLR7—lymph node—colon cancer	0.0128	0.0615	CbGeAlD
Imiquimod—CYP1A2—renal system—colon cancer	0.00492	0.0236	CbGeAlD
Imiquimod—CYP1A2—digestive system—colon cancer	0.00404	0.0194	CbGeAlD
Imiquimod—CYP3A4—renal system—colon cancer	0.00356	0.0171	CbGeAlD
Imiquimod—CYP1A2—liver—colon cancer	0.00301	0.0144	CbGeAlD
Imiquimod—CYP3A4—digestive system—colon cancer	0.00292	0.014	CbGeAlD
Imiquimod—CYP3A4—liver—colon cancer	0.00218	0.0105	CbGeAlD
Imiquimod—Agitation—Vincristine—colon cancer	0.00144	0.00182	CcSEcCtD
Imiquimod—Sweating increased—Capecitabine—colon cancer	0.00143	0.00181	CcSEcCtD
Imiquimod—Ill-defined disorder—Irinotecan—colon cancer	0.00142	0.00179	CcSEcCtD
Imiquimod—Bronchitis—Capecitabine—colon cancer	0.00141	0.00179	CcSEcCtD
Imiquimod—Pancytopenia—Capecitabine—colon cancer	0.0014	0.00176	CcSEcCtD
Imiquimod—Malaise—Irinotecan—colon cancer	0.00138	0.00174	CcSEcCtD
Imiquimod—Dysuria—Capecitabine—colon cancer	0.00137	0.00174	CcSEcCtD
Imiquimod—Syncope—Irinotecan—colon cancer	0.00137	0.00173	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Capecitabine—colon cancer	0.00137	0.00173	CcSEcCtD
Imiquimod—Convulsion—Vincristine—colon cancer	0.00136	0.00172	CcSEcCtD
Imiquimod—Hypertension—Vincristine—colon cancer	0.00136	0.00171	CcSEcCtD
Imiquimod—Loss of consciousness—Irinotecan—colon cancer	0.00135	0.0017	CcSEcCtD
Imiquimod—Dermatitis exfoliative—Methotrexate—colon cancer	0.00134	0.00169	CcSEcCtD
Imiquimod—Photosensitivity reaction—Capecitabine—colon cancer	0.00134	0.00169	CcSEcCtD
Imiquimod—Myalgia—Vincristine—colon cancer	0.00134	0.00169	CcSEcCtD
Imiquimod—Cough—Irinotecan—colon cancer	0.00134	0.00169	CcSEcCtD
Imiquimod—Hypertension—Irinotecan—colon cancer	0.00132	0.00167	CcSEcCtD
Imiquimod—Infestation NOS—Capecitabine—colon cancer	0.00131	0.00166	CcSEcCtD
Imiquimod—Infestation—Capecitabine—colon cancer	0.00131	0.00166	CcSEcCtD
Imiquimod—Depression—Capecitabine—colon cancer	0.00131	0.00165	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.0013	0.00164	CcSEcCtD
Imiquimod—Acute coronary syndrome—Capecitabine—colon cancer	0.00129	0.00163	CcSEcCtD
Imiquimod—Lethargy—Methotrexate—colon cancer	0.00129	0.00163	CcSEcCtD
Imiquimod—Cerebrovascular accident—Methotrexate—colon cancer	0.00129	0.00163	CcSEcCtD
Imiquimod—Discomfort—Irinotecan—colon cancer	0.00129	0.00163	CcSEcCtD
Imiquimod—Neuropathy peripheral—Capecitabine—colon cancer	0.00128	0.00162	CcSEcCtD
Imiquimod—Myocardial infarction—Capecitabine—colon cancer	0.00128	0.00162	CcSEcCtD
Imiquimod—Oedema—Vincristine—colon cancer	0.00128	0.00162	CcSEcCtD
Imiquimod—Infection—Vincristine—colon cancer	0.00127	0.00161	CcSEcCtD
Imiquimod—Conjunctivitis—Capecitabine—colon cancer	0.00127	0.00161	CcSEcCtD
Imiquimod—Urinary tract infection—Capecitabine—colon cancer	0.00127	0.00161	CcSEcCtD
Imiquimod—Convulsion—Fluorouracil—colon cancer	0.00127	0.0016	CcSEcCtD
Imiquimod—Nervous system disorder—Vincristine—colon cancer	0.00126	0.00159	CcSEcCtD
Imiquimod—Oedema—Irinotecan—colon cancer	0.00125	0.00158	CcSEcCtD
Imiquimod—Chest pain—Fluorouracil—colon cancer	0.00125	0.00158	CcSEcCtD
Imiquimod—Myalgia—Fluorouracil—colon cancer	0.00125	0.00158	CcSEcCtD
Imiquimod—Infection—Irinotecan—colon cancer	0.00124	0.00157	CcSEcCtD
Imiquimod—Hyperhidrosis—Vincristine—colon cancer	0.00124	0.00157	CcSEcCtD
Imiquimod—Hepatobiliary disease—Capecitabine—colon cancer	0.00124	0.00157	CcSEcCtD
Imiquimod—Discomfort—Fluorouracil—colon cancer	0.00123	0.00156	CcSEcCtD
Imiquimod—Shock—Irinotecan—colon cancer	0.00123	0.00155	CcSEcCtD
Imiquimod—Nervous system disorder—Irinotecan—colon cancer	0.00123	0.00155	CcSEcCtD
Imiquimod—Anorexia—Vincristine—colon cancer	0.00122	0.00154	CcSEcCtD
Imiquimod—Irritability—Methotrexate—colon cancer	0.00121	0.00153	CcSEcCtD
Imiquimod—Hyperhidrosis—Irinotecan—colon cancer	0.00121	0.00152	CcSEcCtD
Imiquimod—Oedema—Fluorouracil—colon cancer	0.0012	0.00151	CcSEcCtD
Imiquimod—Anorexia—Irinotecan—colon cancer	0.00119	0.0015	CcSEcCtD
Imiquimod—Infection—Fluorouracil—colon cancer	0.00119	0.0015	CcSEcCtD
Imiquimod—Haemoglobin—Capecitabine—colon cancer	0.00118	0.00149	CcSEcCtD
Imiquimod—Rhinitis—Capecitabine—colon cancer	0.00118	0.00149	CcSEcCtD
Imiquimod—Haemorrhage—Capecitabine—colon cancer	0.00118	0.00149	CcSEcCtD
Imiquimod—Nervous system disorder—Fluorouracil—colon cancer	0.00117	0.00148	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Vincristine—colon cancer	0.00117	0.00148	CcSEcCtD
Imiquimod—Pharyngitis—Capecitabine—colon cancer	0.00117	0.00147	CcSEcCtD
Imiquimod—Tachycardia—Fluorouracil—colon cancer	0.00117	0.00147	CcSEcCtD
Imiquimod—Urinary tract disorder—Capecitabine—colon cancer	0.00116	0.00147	CcSEcCtD
Imiquimod—Insomnia—Vincristine—colon cancer	0.00116	0.00146	CcSEcCtD
Imiquimod—Connective tissue disorder—Capecitabine—colon cancer	0.00116	0.00146	CcSEcCtD
Imiquimod—Urethral disorder—Capecitabine—colon cancer	0.00115	0.00146	CcSEcCtD
Imiquimod—Paraesthesia—Vincristine—colon cancer	0.00115	0.00145	CcSEcCtD
Imiquimod—Breast disorder—Methotrexate—colon cancer	0.00114	0.00145	CcSEcCtD
Imiquimod—Anorexia—Fluorouracil—colon cancer	0.00114	0.00144	CcSEcCtD
Imiquimod—Visual impairment—Capecitabine—colon cancer	0.00113	0.00143	CcSEcCtD
Imiquimod—Insomnia—Irinotecan—colon cancer	0.00113	0.00143	CcSEcCtD
Imiquimod—Paraesthesia—Irinotecan—colon cancer	0.00112	0.00142	CcSEcCtD
Imiquimod—Decreased appetite—Vincristine—colon cancer	0.00112	0.00141	CcSEcCtD
Imiquimod—Dyspnoea—Irinotecan—colon cancer	0.00111	0.00141	CcSEcCtD
Imiquimod—Erythema multiforme—Capecitabine—colon cancer	0.00111	0.00141	CcSEcCtD
Imiquimod—Somnolence—Irinotecan—colon cancer	0.00111	0.0014	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Vincristine—colon cancer	0.00111	0.0014	CcSEcCtD
Imiquimod—Fatigue—Vincristine—colon cancer	0.00111	0.0014	CcSEcCtD
Imiquimod—Eye disorder—Capecitabine—colon cancer	0.0011	0.00139	CcSEcCtD
Imiquimod—Dyspepsia—Irinotecan—colon cancer	0.0011	0.00139	CcSEcCtD
Imiquimod—Tinnitus—Capecitabine—colon cancer	0.0011	0.00139	CcSEcCtD
Imiquimod—Pain—Vincristine—colon cancer	0.0011	0.00139	CcSEcCtD
Imiquimod—Flushing—Capecitabine—colon cancer	0.00109	0.00138	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00109	0.00138	CcSEcCtD
Imiquimod—Decreased appetite—Irinotecan—colon cancer	0.00109	0.00137	CcSEcCtD
Imiquimod—Insomnia—Fluorouracil—colon cancer	0.00108	0.00137	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Irinotecan—colon cancer	0.00108	0.00136	CcSEcCtD
Imiquimod—Fatigue—Irinotecan—colon cancer	0.00108	0.00136	CcSEcCtD
Imiquimod—Paraesthesia—Fluorouracil—colon cancer	0.00107	0.00136	CcSEcCtD
Imiquimod—Pain—Irinotecan—colon cancer	0.00107	0.00135	CcSEcCtD
Imiquimod—Angiopathy—Capecitabine—colon cancer	0.00107	0.00135	CcSEcCtD
Imiquimod—Dyspnoea—Fluorouracil—colon cancer	0.00107	0.00135	CcSEcCtD
Imiquimod—Somnolence—Fluorouracil—colon cancer	0.00106	0.00134	CcSEcCtD
Imiquimod—Immune system disorder—Capecitabine—colon cancer	0.00106	0.00134	CcSEcCtD
Imiquimod—Mediastinal disorder—Capecitabine—colon cancer	0.00106	0.00134	CcSEcCtD
Imiquimod—Chills—Capecitabine—colon cancer	0.00106	0.00133	CcSEcCtD
Imiquimod—Dyspepsia—Fluorouracil—colon cancer	0.00105	0.00133	CcSEcCtD
Imiquimod—Arrhythmia—Capecitabine—colon cancer	0.00105	0.00133	CcSEcCtD
Imiquimod—Gastrointestinal pain—Vincristine—colon cancer	0.00105	0.00132	CcSEcCtD
Imiquimod—Decreased appetite—Fluorouracil—colon cancer	0.00104	0.00131	CcSEcCtD
Imiquimod—Alopecia—Capecitabine—colon cancer	0.00104	0.00131	CcSEcCtD
Imiquimod—Pancytopenia—Methotrexate—colon cancer	0.00104	0.00131	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00103	0.0013	CcSEcCtD
Imiquimod—Mental disorder—Capecitabine—colon cancer	0.00103	0.0013	CcSEcCtD
Imiquimod—Feeling abnormal—Irinotecan—colon cancer	0.00103	0.0013	CcSEcCtD
Imiquimod—Malnutrition—Capecitabine—colon cancer	0.00102	0.00129	CcSEcCtD
Imiquimod—Erythema—Capecitabine—colon cancer	0.00102	0.00129	CcSEcCtD
Imiquimod—Dysuria—Methotrexate—colon cancer	0.00102	0.00129	CcSEcCtD
Imiquimod—Pain—Fluorouracil—colon cancer	0.00102	0.00129	CcSEcCtD
Imiquimod—Gastrointestinal pain—Irinotecan—colon cancer	0.00102	0.00129	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Methotrexate—colon cancer	0.00102	0.00128	CcSEcCtD
Imiquimod—Abdominal pain—Vincristine—colon cancer	0.00101	0.00128	CcSEcCtD
Imiquimod—Body temperature increased—Vincristine—colon cancer	0.00101	0.00128	CcSEcCtD
Imiquimod—Erectile dysfunction—Methotrexate—colon cancer	0.00101	0.00127	CcSEcCtD
Imiquimod—Photosensitivity reaction—Methotrexate—colon cancer	0.000999	0.00126	CcSEcCtD
Imiquimod—Back pain—Capecitabine—colon cancer	0.000991	0.00125	CcSEcCtD
Imiquimod—Abdominal pain—Irinotecan—colon cancer	0.000988	0.00125	CcSEcCtD
Imiquimod—Body temperature increased—Irinotecan—colon cancer	0.000988	0.00125	CcSEcCtD
Imiquimod—Feeling abnormal—Fluorouracil—colon cancer	0.000986	0.00124	CcSEcCtD
Imiquimod—Infestation—Methotrexate—colon cancer	0.000976	0.00123	CcSEcCtD
Imiquimod—Infestation NOS—Methotrexate—colon cancer	0.000976	0.00123	CcSEcCtD
Imiquimod—Depression—Methotrexate—colon cancer	0.000973	0.00123	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000967	0.00122	CcSEcCtD
Imiquimod—Ill-defined disorder—Capecitabine—colon cancer	0.000951	0.0012	CcSEcCtD
Imiquimod—Urticaria—Fluorouracil—colon cancer	0.00095	0.0012	CcSEcCtD
Imiquimod—Conjunctivitis—Methotrexate—colon cancer	0.000949	0.0012	CcSEcCtD
Imiquimod—Body temperature increased—Fluorouracil—colon cancer	0.000946	0.00119	CcSEcCtD
Imiquimod—Hypersensitivity—Vincristine—colon cancer	0.000945	0.00119	CcSEcCtD
Imiquimod—Malaise—Capecitabine—colon cancer	0.000924	0.00117	CcSEcCtD
Imiquimod—Hepatobiliary disease—Methotrexate—colon cancer	0.000923	0.00117	CcSEcCtD
Imiquimod—Hypersensitivity—Irinotecan—colon cancer	0.00092	0.00116	CcSEcCtD
Imiquimod—Asthenia—Vincristine—colon cancer	0.00092	0.00116	CcSEcCtD
Imiquimod—Syncope—Capecitabine—colon cancer	0.000919	0.00116	CcSEcCtD
Imiquimod—Palpitations—Capecitabine—colon cancer	0.000905	0.00114	CcSEcCtD
Imiquimod—Loss of consciousness—Capecitabine—colon cancer	0.0009	0.00114	CcSEcCtD
Imiquimod—Asthenia—Irinotecan—colon cancer	0.000896	0.00113	CcSEcCtD
Imiquimod—Cough—Capecitabine—colon cancer	0.000894	0.00113	CcSEcCtD
Imiquimod—Hypertension—Capecitabine—colon cancer	0.000884	0.00112	CcSEcCtD
Imiquimod—Hypersensitivity—Fluorouracil—colon cancer	0.000881	0.00111	CcSEcCtD
Imiquimod—Haemoglobin—Methotrexate—colon cancer	0.00088	0.00111	CcSEcCtD
Imiquimod—Diarrhoea—Vincristine—colon cancer	0.000878	0.00111	CcSEcCtD
Imiquimod—Haemorrhage—Methotrexate—colon cancer	0.000876	0.00111	CcSEcCtD
Imiquimod—Myalgia—Capecitabine—colon cancer	0.000872	0.0011	CcSEcCtD
Imiquimod—Chest pain—Capecitabine—colon cancer	0.000872	0.0011	CcSEcCtD
Imiquimod—Arthralgia—Capecitabine—colon cancer	0.000872	0.0011	CcSEcCtD
Imiquimod—Pharyngitis—Methotrexate—colon cancer	0.000869	0.0011	CcSEcCtD
Imiquimod—Anxiety—Capecitabine—colon cancer	0.000869	0.0011	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000866	0.00109	CcSEcCtD
Imiquimod—Urinary tract disorder—Methotrexate—colon cancer	0.000865	0.00109	CcSEcCtD
Imiquimod—Discomfort—Capecitabine—colon cancer	0.000862	0.00109	CcSEcCtD
Imiquimod—Urethral disorder—Methotrexate—colon cancer	0.000859	0.00108	CcSEcCtD
Imiquimod—Diarrhoea—Irinotecan—colon cancer	0.000855	0.00108	CcSEcCtD
Imiquimod—Dry mouth—Capecitabine—colon cancer	0.000853	0.00108	CcSEcCtD
Imiquimod—Dizziness—Vincristine—colon cancer	0.000848	0.00107	CcSEcCtD
Imiquimod—Pruritus—Fluorouracil—colon cancer	0.000846	0.00107	CcSEcCtD
Imiquimod—Visual impairment—Methotrexate—colon cancer	0.000844	0.00107	CcSEcCtD
Imiquimod—Oedema—Capecitabine—colon cancer	0.000836	0.00106	CcSEcCtD
Imiquimod—Infection—Capecitabine—colon cancer	0.000831	0.00105	CcSEcCtD
Imiquimod—Erythema multiforme—Methotrexate—colon cancer	0.000828	0.00105	CcSEcCtD
Imiquimod—Dizziness—Irinotecan—colon cancer	0.000826	0.00104	CcSEcCtD
Imiquimod—Shock—Capecitabine—colon cancer	0.000823	0.00104	CcSEcCtD
Imiquimod—Nervous system disorder—Capecitabine—colon cancer	0.00082	0.00104	CcSEcCtD
Imiquimod—Eye disorder—Methotrexate—colon cancer	0.000819	0.00103	CcSEcCtD
Imiquimod—Diarrhoea—Fluorouracil—colon cancer	0.000819	0.00103	CcSEcCtD
Imiquimod—Tinnitus—Methotrexate—colon cancer	0.000817	0.00103	CcSEcCtD
Imiquimod—Tachycardia—Capecitabine—colon cancer	0.000816	0.00103	CcSEcCtD
Imiquimod—Vomiting—Vincristine—colon cancer	0.000816	0.00103	CcSEcCtD
Imiquimod—Skin disorder—Capecitabine—colon cancer	0.000812	0.00103	CcSEcCtD
Imiquimod—Rash—Vincristine—colon cancer	0.000809	0.00102	CcSEcCtD
Imiquimod—Hyperhidrosis—Capecitabine—colon cancer	0.000808	0.00102	CcSEcCtD
Imiquimod—Dermatitis—Vincristine—colon cancer	0.000808	0.00102	CcSEcCtD
Imiquimod—Headache—Vincristine—colon cancer	0.000804	0.00101	CcSEcCtD
Imiquimod—Anorexia—Capecitabine—colon cancer	0.000797	0.00101	CcSEcCtD
Imiquimod—Angiopathy—Methotrexate—colon cancer	0.000795	0.001	CcSEcCtD
Imiquimod—Vomiting—Irinotecan—colon cancer	0.000794	0.001	CcSEcCtD
Imiquimod—Immune system disorder—Methotrexate—colon cancer	0.000791	0.000999	CcSEcCtD
Imiquimod—Dizziness—Fluorouracil—colon cancer	0.000791	0.000999	CcSEcCtD
Imiquimod—Mediastinal disorder—Methotrexate—colon cancer	0.00079	0.000997	CcSEcCtD
Imiquimod—Rash—Irinotecan—colon cancer	0.000788	0.000995	CcSEcCtD
Imiquimod—Dermatitis—Irinotecan—colon cancer	0.000787	0.000994	CcSEcCtD
Imiquimod—Chills—Methotrexate—colon cancer	0.000786	0.000993	CcSEcCtD
Imiquimod—Headache—Irinotecan—colon cancer	0.000783	0.000988	CcSEcCtD
Imiquimod—Alopecia—Methotrexate—colon cancer	0.000774	0.000978	CcSEcCtD
Imiquimod—Mental disorder—Methotrexate—colon cancer	0.000768	0.000969	CcSEcCtD
Imiquimod—Erythema—Methotrexate—colon cancer	0.000763	0.000963	CcSEcCtD
Imiquimod—Malnutrition—Methotrexate—colon cancer	0.000763	0.000963	CcSEcCtD
Imiquimod—Nausea—Vincristine—colon cancer	0.000762	0.000962	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000762	0.000962	CcSEcCtD
Imiquimod—Vomiting—Fluorouracil—colon cancer	0.000761	0.000961	CcSEcCtD
Imiquimod—Insomnia—Capecitabine—colon cancer	0.000756	0.000955	CcSEcCtD
Imiquimod—Rash—Fluorouracil—colon cancer	0.000754	0.000953	CcSEcCtD
Imiquimod—Dermatitis—Fluorouracil—colon cancer	0.000754	0.000952	CcSEcCtD
Imiquimod—Paraesthesia—Capecitabine—colon cancer	0.000751	0.000948	CcSEcCtD
Imiquimod—Headache—Fluorouracil—colon cancer	0.00075	0.000946	CcSEcCtD
Imiquimod—Dyspnoea—Capecitabine—colon cancer	0.000745	0.000941	CcSEcCtD
Imiquimod—Nausea—Irinotecan—colon cancer	0.000742	0.000937	CcSEcCtD
Imiquimod—Back pain—Methotrexate—colon cancer	0.000738	0.000931	CcSEcCtD
Imiquimod—Dyspepsia—Capecitabine—colon cancer	0.000736	0.000929	CcSEcCtD
Imiquimod—Decreased appetite—Capecitabine—colon cancer	0.000727	0.000918	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Capecitabine—colon cancer	0.000722	0.000911	CcSEcCtD
Imiquimod—Fatigue—Capecitabine—colon cancer	0.000721	0.00091	CcSEcCtD
Imiquimod—Pain—Capecitabine—colon cancer	0.000715	0.000903	CcSEcCtD
Imiquimod—Nausea—Fluorouracil—colon cancer	0.000711	0.000897	CcSEcCtD
Imiquimod—Ill-defined disorder—Methotrexate—colon cancer	0.000708	0.000893	CcSEcCtD
Imiquimod—Feeling abnormal—Capecitabine—colon cancer	0.000689	0.00087	CcSEcCtD
Imiquimod—Malaise—Methotrexate—colon cancer	0.000688	0.000868	CcSEcCtD
Imiquimod—Gastrointestinal pain—Capecitabine—colon cancer	0.000684	0.000863	CcSEcCtD
Imiquimod—Cough—Methotrexate—colon cancer	0.000665	0.00084	CcSEcCtD
Imiquimod—Urticaria—Capecitabine—colon cancer	0.000664	0.000839	CcSEcCtD
Imiquimod—Abdominal pain—Capecitabine—colon cancer	0.000661	0.000835	CcSEcCtD
Imiquimod—Body temperature increased—Capecitabine—colon cancer	0.000661	0.000835	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—colon cancer	0.000661	0.000834	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—colon cancer	0.000649	0.00082	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—colon cancer	0.000649	0.00082	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—colon cancer	0.000649	0.00082	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000645	0.000814	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—colon cancer	0.000641	0.00081	CcSEcCtD
Imiquimod—Infection—Methotrexate—colon cancer	0.000618	0.000781	CcSEcCtD
Imiquimod—Hypersensitivity—Capecitabine—colon cancer	0.000616	0.000778	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—colon cancer	0.00061	0.000771	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—colon cancer	0.000605	0.000763	CcSEcCtD
Imiquimod—Hyperhidrosis—Methotrexate—colon cancer	0.000602	0.00076	CcSEcCtD
Imiquimod—Asthenia—Capecitabine—colon cancer	0.0006	0.000757	CcSEcCtD
Imiquimod—Anorexia—Methotrexate—colon cancer	0.000593	0.000749	CcSEcCtD
Imiquimod—Pruritus—Capecitabine—colon cancer	0.000592	0.000747	CcSEcCtD
Imiquimod—Diarrhoea—Capecitabine—colon cancer	0.000572	0.000722	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000567	0.000716	CcSEcCtD
Imiquimod—Insomnia—Methotrexate—colon cancer	0.000563	0.000711	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—colon cancer	0.000559	0.000706	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—colon cancer	0.000555	0.000701	CcSEcCtD
Imiquimod—Somnolence—Methotrexate—colon cancer	0.000553	0.000699	CcSEcCtD
Imiquimod—Dizziness—Capecitabine—colon cancer	0.000553	0.000698	CcSEcCtD
Imiquimod—Dyspepsia—Methotrexate—colon cancer	0.000548	0.000692	CcSEcCtD
Imiquimod—Decreased appetite—Methotrexate—colon cancer	0.000541	0.000683	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—colon cancer	0.000537	0.000679	CcSEcCtD
Imiquimod—Fatigue—Methotrexate—colon cancer	0.000537	0.000678	CcSEcCtD
Imiquimod—Pain—Methotrexate—colon cancer	0.000532	0.000672	CcSEcCtD
Imiquimod—Vomiting—Capecitabine—colon cancer	0.000532	0.000671	CcSEcCtD
Imiquimod—Rash—Capecitabine—colon cancer	0.000527	0.000666	CcSEcCtD
Imiquimod—Dermatitis—Capecitabine—colon cancer	0.000527	0.000665	CcSEcCtD
Imiquimod—Headache—Capecitabine—colon cancer	0.000524	0.000661	CcSEcCtD
Imiquimod—Feeling abnormal—Methotrexate—colon cancer	0.000513	0.000648	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—colon cancer	0.000509	0.000643	CcSEcCtD
Imiquimod—Nausea—Capecitabine—colon cancer	0.000497	0.000627	CcSEcCtD
Imiquimod—Urticaria—Methotrexate—colon cancer	0.000494	0.000624	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—colon cancer	0.000492	0.000621	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—colon cancer	0.000492	0.000621	CcSEcCtD
Imiquimod—Hypersensitivity—Methotrexate—colon cancer	0.000459	0.000579	CcSEcCtD
Imiquimod—Asthenia—Methotrexate—colon cancer	0.000447	0.000564	CcSEcCtD
Imiquimod—Pruritus—Methotrexate—colon cancer	0.00044	0.000556	CcSEcCtD
Imiquimod—Diarrhoea—Methotrexate—colon cancer	0.000426	0.000538	CcSEcCtD
Imiquimod—Dizziness—Methotrexate—colon cancer	0.000412	0.00052	CcSEcCtD
Imiquimod—Vomiting—Methotrexate—colon cancer	0.000396	0.0005	CcSEcCtD
Imiquimod—Rash—Methotrexate—colon cancer	0.000392	0.000496	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—colon cancer	0.000392	0.000495	CcSEcCtD
Imiquimod—Headache—Methotrexate—colon cancer	0.00039	0.000492	CcSEcCtD
Imiquimod—Nausea—Methotrexate—colon cancer	0.00037	0.000467	CcSEcCtD
